Conferences
21–22 February 2017, Manchester, UK
12th Annual Biomarkers Congress
Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions. Over 55 presentations, case studies, round-table and panel discussions focused on the key innovations of biomarker research in discovery and development, companion diagnostics, data management, innovative biology, precision medicine and clinical biomarkers.
6 Interactive Streams:
- Biomarkers in Drug Discovery & Development – Therapeutic areas: Autoimmune, Immuno-oncology, Neuroscience, Oncology
- Personalised Medicine, Companion Diagnostics and Development
- Biomarker Discovery, Verification & Validation, and Safety – Therapeutic areas: Cardiovascular, Rheumatology, COPD, Rare Diseases and Microbiome
- Innovations in Biomarkers Research, Assay Development, Imaging, Data Management
- Biomarker in Clinical Development & Clinical Trials
- Innovative Biology- NGS & Genomic Markers, Clinical Testing and Diagnostics Development
Visit the conference website at www.biomarkers-congress.com or contact Danielle Dalby for a copy of the conference programme: [email protected]
